 | • レポートコード：GIR201108513 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、鎌状赤血球症（SCD）治療薬の世界市場を調査対象にし、鎌状赤血球症（SCD）治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Acceleron Pharma Inc、bluebird bio Inc、Annexin Pharmaceuticals AB、Addmedica SAS、Bioverativ Inc、Angiocrine Bioscience Inc、Calimmune Inc、Bio Products Laboratory Ltd、ArQule Inc、Bristol-Myers Squibb Co、Errant Gene Therapeutics LLC、Gilead Sciences Inc、CRISPR Therapeutics、Gamida Cell Ltd、Editas Medicine Inc、CSL Ltd、Global Blood Therapeutics Inc、Genethon SA、Daiichi Sankyo Co Ltd ・メーカー別販売量、売上、市場シェア ・鎌状赤血球症（SCD）治療薬の地域別市場分析 ・鎌状赤血球症（SCD）治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・鎌状赤血球症（SCD）治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・鎌状赤血球症（SCD）治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・鎌状赤血球症（SCD）治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・鎌状赤血球症（SCD）治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・鎌状赤血球症（SCD）治療薬の種類別市場規模2015-2020：ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他 ・鎌状赤血球症（SCD）治療薬の用途別市場規模2015-2020：病院、クリニック、その他 ・鎌状赤血球症（SCD）治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Sickle Cell Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Sickle Cell Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sickle Cell Disease Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sickle Cell Disease Drug market has been segmented into
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others
By Application, Sickle Cell Disease Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sickle Cell Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Sickle Cell Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sickle Cell Disease Drug market.
The report offers in-depth assessment of the growth and other aspects of the Sickle Cell Disease Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Sickle Cell Disease Drug Market Share Analysis
Sickle Cell Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sickle Cell Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sickle Cell Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Sickle Cell Disease Drug are:
Acceleron Pharma Inc
bluebird bio Inc
Annexin Pharmaceuticals AB
Addmedica SAS
Bioverativ Inc
Angiocrine Bioscience Inc
Calimmune Inc
Bio Products Laboratory Ltd
ArQule Inc
Bristol-Myers Squibb Co
Errant Gene Therapeutics LLC
Gilead Sciences Inc
CRISPR Therapeutics
Gamida Cell Ltd
Editas Medicine Inc
CSL Ltd
Global Blood Therapeutics Inc
Genethon SA
Daiichi Sankyo Co Ltd
Among other players domestic and global, Sickle Cell Disease Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sickle Cell Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sickle Cell Disease Drug, with price, sales, revenue and global market share of Sickle Cell Disease Drug in 2018 and 2019.
Chapter 3, the Sickle Cell Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sickle Cell Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Sickle Cell Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Sickle Cell Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Sickle Cell Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sickle Cell Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ARQ-092
1.2.3 BIVV-003
1.2.4 CAL-H
1.2.5 CTX-001
1.2.6 DRX-194
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sickle Cell Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Sickle Cell Disease Drug Market
1.4.1 Global Sickle Cell Disease Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Acceleron Pharma Inc
2.1.1 Acceleron Pharma Inc Details
2.1.2 Acceleron Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Acceleron Pharma Inc SWOT Analysis
2.1.4 Acceleron Pharma Inc Product and Services
2.1.5 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 bluebird bio Inc
2.2.1 bluebird bio Inc Details
2.2.2 bluebird bio Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 bluebird bio Inc SWOT Analysis
2.2.4 bluebird bio Inc Product and Services
2.2.5 bluebird bio Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Annexin Pharmaceuticals AB
2.3.1 Annexin Pharmaceuticals AB Details
2.3.2 Annexin Pharmaceuticals AB Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Annexin Pharmaceuticals AB SWOT Analysis
2.3.4 Annexin Pharmaceuticals AB Product and Services
2.3.5 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Addmedica SAS
2.4.1 Addmedica SAS Details
2.4.2 Addmedica SAS Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Addmedica SAS SWOT Analysis
2.4.4 Addmedica SAS Product and Services
2.4.5 Addmedica SAS Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bioverativ Inc
2.5.1 Bioverativ Inc Details
2.5.2 Bioverativ Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bioverativ Inc SWOT Analysis
2.5.4 Bioverativ Inc Product and Services
2.5.5 Bioverativ Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Angiocrine Bioscience Inc
2.6.1 Angiocrine Bioscience Inc Details
2.6.2 Angiocrine Bioscience Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Angiocrine Bioscience Inc SWOT Analysis
2.6.4 Angiocrine Bioscience Inc Product and Services
2.6.5 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Calimmune Inc
2.7.1 Calimmune Inc Details
2.7.2 Calimmune Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Calimmune Inc SWOT Analysis
2.7.4 Calimmune Inc Product and Services
2.7.5 Calimmune Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio Products Laboratory Ltd
2.8.1 Bio Products Laboratory Ltd Details
2.8.2 Bio Products Laboratory Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bio Products Laboratory Ltd SWOT Analysis
2.8.4 Bio Products Laboratory Ltd Product and Services
2.8.5 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 ArQule Inc
2.9.1 ArQule Inc Details
2.9.2 ArQule Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 ArQule Inc SWOT Analysis
2.9.4 ArQule Inc Product and Services
2.9.5 ArQule Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb Co
2.10.1 Bristol-Myers Squibb Co Details
2.10.2 Bristol-Myers Squibb Co Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb Co SWOT Analysis
2.10.4 Bristol-Myers Squibb Co Product and Services
2.10.5 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Errant Gene Therapeutics LLC
2.11.1 Errant Gene Therapeutics LLC Details
2.11.2 Errant Gene Therapeutics LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Errant Gene Therapeutics LLC SWOT Analysis
2.11.4 Errant Gene Therapeutics LLC Product and Services
2.11.5 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Gilead Sciences Inc
2.12.1 Gilead Sciences Inc Details
2.12.2 Gilead Sciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Gilead Sciences Inc SWOT Analysis
2.12.4 Gilead Sciences Inc Product and Services
2.12.5 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 CRISPR Therapeutics
2.13.1 CRISPR Therapeutics Details
2.13.2 CRISPR Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 CRISPR Therapeutics SWOT Analysis
2.13.4 CRISPR Therapeutics Product and Services
2.13.5 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Gamida Cell Ltd
2.14.1 Gamida Cell Ltd Details
2.14.2 Gamida Cell Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Gamida Cell Ltd SWOT Analysis
2.14.4 Gamida Cell Ltd Product and Services
2.14.5 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Editas Medicine Inc
2.15.1 Editas Medicine Inc Details
2.15.2 Editas Medicine Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Editas Medicine Inc SWOT Analysis
2.15.4 Editas Medicine Inc Product and Services
2.15.5 Editas Medicine Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 CSL Ltd
2.16.1 CSL Ltd Details
2.16.2 CSL Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 CSL Ltd SWOT Analysis
2.16.4 CSL Ltd Product and Services
2.16.5 CSL Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Global Blood Therapeutics Inc
2.17.1 Global Blood Therapeutics Inc Details
2.17.2 Global Blood Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Global Blood Therapeutics Inc SWOT Analysis
2.17.4 Global Blood Therapeutics Inc Product and Services
2.17.5 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Genethon SA
2.18.1 Genethon SA Details
2.18.2 Genethon SA Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Genethon SA SWOT Analysis
2.18.4 Genethon SA Product and Services
2.18.5 Genethon SA Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Daiichi Sankyo Co Ltd
2.19.1 Daiichi Sankyo Co Ltd Details
2.19.2 Daiichi Sankyo Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Daiichi Sankyo Co Ltd SWOT Analysis
2.19.4 Daiichi Sankyo Co Ltd Product and Services
2.19.5 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Sickle Cell Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Sickle Cell Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sickle Cell Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Sickle Cell Disease Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Sickle Cell Disease Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Sickle Cell Disease Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Sickle Cell Disease Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
4.3 Europe Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
4.5 South America Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Sickle Cell Disease Drug Sales, Revenue and Market Share by Country
5.1.1 North America Sickle Cell Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Sickle Cell Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
5.3 Canada Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Sickle Cell Disease Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Sickle Cell Disease Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Sickle Cell Disease Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
6.3 UK Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
6.4 France Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
6.5 Russia Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
6.6 Italy Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sickle Cell Disease Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Sickle Cell Disease Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Sickle Cell Disease Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
7.3 Japan Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
7.4 Korea Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
7.5 India Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
7.7 Australia Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Sickle Cell Disease Drug Sales, Revenue and Market Share by Country
8.1.1 South America Sickle Cell Disease Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Sickle Cell Disease Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sickle Cell Disease Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Sickle Cell Disease Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Sickle Cell Disease Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Sickle Cell Disease Drug Sales and Market Share by Type (2015-2020)
10.2 Global Sickle Cell Disease Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Sickle Cell Disease Drug Price by Type (2015-2020)
11 Global Sickle Cell Disease Drug Market Segment by Application
11.1 Global Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
11.2 Global Sickle Cell Disease Drug Revenue Market Share by Application (2015-2020)
11.3 Global Sickle Cell Disease Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Sickle Cell Disease Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Sickle Cell Disease Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Sickle Cell Disease Drug Market Forecast (2021-2025)
12.2.2 Europe Sickle Cell Disease Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Sickle Cell Disease Drug Market Forecast (2021-2025)
12.2.4 South America Sickle Cell Disease Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Sickle Cell Disease Drug Market Forecast (2021-2025)
12.3 Sickle Cell Disease Drug Market Forecast by Type (2021-2025)
12.3.1 Global Sickle Cell Disease Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Sickle Cell Disease Drug Market Share Forecast by Type (2021-2025)
12.4 Sickle Cell Disease Drug Market Forecast by Application (2021-2025)
12.4.1 Global Sickle Cell Disease Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Sickle Cell Disease Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Sickle Cell Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sickle Cell Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sickle Cell Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Acceleron Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 8. Acceleron Pharma Inc Sickle Cell Disease Drug Major Business
Table 9. Acceleron Pharma Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 10. Acceleron Pharma Inc SWOT Analysis
Table 11. Acceleron Pharma Inc Sickle Cell Disease Drug Product and Services
Table 12. Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. bluebird bio Inc Basic Information, Manufacturing Base and Competitors
Table 14. bluebird bio Inc Sickle Cell Disease Drug Major Business
Table 15. bluebird bio Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 16. bluebird bio Inc SWOT Analysis
Table 17. bluebird bio Inc Sickle Cell Disease Drug Product and Services
Table 18. bluebird bio Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Annexin Pharmaceuticals AB Basic Information, Manufacturing Base and Competitors
Table 20. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Major Business
Table 21. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 22. Annexin Pharmaceuticals AB SWOT Analysis
Table 23. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product and Services
Table 24. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Addmedica SAS Basic Information, Manufacturing Base and Competitors
Table 26. Addmedica SAS Sickle Cell Disease Drug Major Business
Table 27. Addmedica SAS Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 28. Addmedica SAS SWOT Analysis
Table 29. Addmedica SAS Sickle Cell Disease Drug Product and Services
Table 30. Addmedica SAS Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bioverativ Inc Basic Information, Manufacturing Base and Competitors
Table 32. Bioverativ Inc Sickle Cell Disease Drug Major Business
Table 33. Bioverativ Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 34. Bioverativ Inc SWOT Analysis
Table 35. Bioverativ Inc Sickle Cell Disease Drug Product and Services
Table 36. Bioverativ Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Angiocrine Bioscience Inc Basic Information, Manufacturing Base and Competitors
Table 38. Angiocrine Bioscience Inc Sickle Cell Disease Drug Major Business
Table 39. Angiocrine Bioscience Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 40. Angiocrine Bioscience Inc SWOT Analysis
Table 41. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product and Services
Table 42. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Calimmune Inc Basic Information, Manufacturing Base and Competitors
Table 44. Calimmune Inc Sickle Cell Disease Drug Major Business
Table 45. Calimmune Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 46. Calimmune Inc SWOT Analysis
Table 47. Calimmune Inc Sickle Cell Disease Drug Product and Services
Table 48. Calimmune Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bio Products Laboratory Ltd Basic Information, Manufacturing Base and Competitors
Table 50. Bio Products Laboratory Ltd Sickle Cell Disease Drug Major Business
Table 51. Bio Products Laboratory Ltd Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 52. Bio Products Laboratory Ltd SWOT Analysis
Table 53. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product and Services
Table 54. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. ArQule Inc Basic Information, Manufacturing Base and Competitors
Table 56. ArQule Inc Sickle Cell Disease Drug Major Business
Table 57. ArQule Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 58. ArQule Inc SWOT Analysis
Table 59. ArQule Inc Sickle Cell Disease Drug Product and Services
Table 60. ArQule Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 62. Bristol-Myers Squibb Co Sickle Cell Disease Drug Major Business
Table 63. Bristol-Myers Squibb Co Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 64. Bristol-Myers Squibb Co SWOT Analysis
Table 65. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product and Services
Table 66. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Errant Gene Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table 68. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Major Business
Table 69. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 70. Errant Gene Therapeutics LLC SWOT Analysis
Table 71. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product and Services
Table 72. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table 74. Gilead Sciences Inc Sickle Cell Disease Drug Major Business
Table 75. Gilead Sciences Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 76. Gilead Sciences Inc SWOT Analysis
Table 77. Gilead Sciences Inc Sickle Cell Disease Drug Product and Services
Table 78. Gilead Sciences Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. CRISPR Therapeutics Sickle Cell Disease Drug Major Business
Table 81. CRISPR Therapeutics Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 82. CRISPR Therapeutics SWOT Analysis
Table 83. CRISPR Therapeutics Sickle Cell Disease Drug Product and Services
Table 84. CRISPR Therapeutics Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Gamida Cell Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Gamida Cell Ltd Sickle Cell Disease Drug Major Business
Table 87. Gamida Cell Ltd Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 88. Gamida Cell Ltd SWOT Analysis
Table 89. Gamida Cell Ltd Sickle Cell Disease Drug Product and Services
Table 90. Gamida Cell Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Editas Medicine Inc Basic Information, Manufacturing Base and Competitors
Table 92. Editas Medicine Inc Sickle Cell Disease Drug Major Business
Table 93. Editas Medicine Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 94. Editas Medicine Inc SWOT Analysis
Table 95. Editas Medicine Inc Sickle Cell Disease Drug Product and Services
Table 96. Editas Medicine Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. CSL Ltd Basic Information, Manufacturing Base and Competitors
Table 98. CSL Ltd Sickle Cell Disease Drug Major Business
Table 99. CSL Ltd Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 100. CSL Ltd SWOT Analysis
Table 101. CSL Ltd Sickle Cell Disease Drug Product and Services
Table 102. CSL Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Global Blood Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 104. Global Blood Therapeutics Inc Sickle Cell Disease Drug Major Business
Table 105. Global Blood Therapeutics Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 106. Global Blood Therapeutics Inc SWOT Analysis
Table 107. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product and Services
Table 108. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Genethon SA Sickle Cell Disease Drug Type and Application
Table 110. Genethon SA Sickle Cell Disease Drug Major Business
Table 111. Genethon SA Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 112. Genethon SA SWOT Analysis
Table 113. Genethon SA Sickle Cell Disease Drug Product and Services
Table 114. Genethon SA Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Major Business
Table 117. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 118. Daiichi Sankyo Co Ltd SWOT Analysis
Table 119. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product and Services
Table 120. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Global Sickle Cell Disease Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 122. Global Sickle Cell Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 123. Global Sickle Cell Disease Drug Sales by Regions (2015-2020) (K Pcs)
Table 124. Global Sickle Cell Disease Drug Sales Market Share by Regions (2015-2020)
Table 125. Global Sickle Cell Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 126. North America Sickle Cell Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 127. North America Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Table 128. North America Sickle Cell Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 129. North America Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Table 130. Europe Sickle Cell Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 131. Europe Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Table 132. Europe Sickle Cell Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 133. Asia-Pacific Sickle Cell Disease Drug Sales by Regions (2015-2020) (K Pcs)
Table 134. Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Regions (2015-2020)
Table 135. Asia-Pacific Sickle Cell Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 136. South America Sickle Cell Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 137. South America Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Table 138. South America Sickle Cell Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 139. South America Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Table 140. Middle East & Africa Sickle Cell Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 141. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Table 142. Middle East & Africa Sickle Cell Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 143. Middle East & Africa Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Table 144. Global Sickle Cell Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 145. Global Sickle Cell Disease Drug Sales Share by Type (2015-2020)
Table 146. Global Sickle Cell Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 147. Global Sickle Cell Disease Drug Revenue Share by Type (2015-2020)
Table 148. Global Sickle Cell Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 149. Global Sickle Cell Disease Drug Sales Share by Application (2015-2020)
Table 150. Global Sickle Cell Disease Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 151. Global Sickle Cell Disease Drug Market Share Forecast by Regions (2021-2025)
Table 152. Global Sickle Cell Disease Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 153. Global Sickle Cell Disease Drug Market Share Forecast by Type (2021-2025)
Table 154. Global Sickle Cell Disease Drug Sales Forecast by Application (2021-2025)
Table 155. Global Sickle Cell Disease Drug Market Share Forecast by Application (2021-2025)
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Sickle Cell Disease Drug Picture
Figure 2. Global Sales Market Share of Sickle Cell Disease Drug by Type in 2019
Figure 3. ARQ-092 Picture
Figure 4. BIVV-003 Picture
Figure 5. CAL-H Picture
Figure 6. CTX-001 Picture
Figure 7. DRX-194 Picture
Figure 8. Others Picture
Figure 9. Sickle Cell Disease Drug Sales Market Share by Application in 2018
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Sickle Cell Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Sickle Cell Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Sickle Cell Disease Drug Sales Market Share by Manufacturer in 2019
Figure 34. Global Sickle Cell Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Sickle Cell Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Sickle Cell Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Sickle Cell Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Sickle Cell Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 41. Global Sickle Cell Disease Drug Revenue Market Share by Regions in 2018
Figure 42. North America Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
Figure 43. Europe Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
Figure 45. South America Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Sickle Cell Disease Drug Sales and Growth Rate (2015-2020)
Figure 47. North America Sickle Cell Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Figure 49. North America Sickle Cell Disease Drug Sales Market Share by Countries in 2018
Figure 50. North America Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Sickle Cell Disease Drug Revenue Market Share by Countries in 2018
Figure 52. United States Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Sickle Cell Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Sickle Cell Disease Drug Revenue Market Share by Countries in 2019
Figure 58. Germany Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Sickle Cell Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Sickle Cell Disease Drug Revenue Market Share by Regions 2019
Figure 66. China Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Sickle Cell Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Sickle Cell Disease Drug Sales Market Share by Countries in 2019
Figure 73. South America Sickle Cell Disease Drug Revenue Market Share by Countries in 2019
Figure 74. Brazil Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Sickle Cell Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Sickle Cell Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Sickle Cell Disease Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Sickle Cell Disease Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Sickle Cell Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Sickle Cell Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Sickle Cell Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Sickle Cell Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Sickle Cell Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
鎌状赤血球症関連血管閉塞症の世界市場 2020年 Market Overview The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mil…- ベーチェット病治療薬の世界市場 2020年 Market Overview The global Behcet Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Behcet Disease Drug marke…
- アルツハイマー病治療薬の世界市場 2020年 Market Overview The Alzheimer's Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- シャルコー・マリー・トゥース病I型治療薬の世界市場 2020年 Market Overview The global Charcot-Marie-Tooth Disease Type I A Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cha…
- 疾患修飾性抗リウマチ治療薬の世界市場 2020年 Market Overview The global Disease-Modifying Antirheumatic Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Disease-…